PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
92 hedge funds and large institutions have $155M invested in Poseida Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 90 → 92 (+2)
8% less capital invested
Capital invested by funds: $168M → $155M (-$13.7M)
Holders
92
Holding in Top 10
2
Calls
$1.32M
Puts
$175K
Top Buyers
| 1 | +$869K | |
| 2 | +$645K | |
| 3 | +$398K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$382K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$283K |
Top Sellers
| 1 | -$827K | |
| 2 | -$654K | |
| 3 | -$645K | |
| 4 |
Morgan Stanley
New York
|
-$307K |
| 5 |
AGP
Artia Global Partners
Miami,
Florida
|
-$274K |